About this trial
A review of the literature did not identify any studies that assessed knowledge of cardiovascular disease risk factors and healthy lifestyle behaviours in patients with ankylosing spondylitis. The aim of this study is to assess knowledge of cardiovascular disease risk factors, healthy lifestyle behaviours and physical activity levels in patients with ankylosing spondylitis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of ankylosing spondylitis according to ASAS diagnostic criteria
Being aged 18-65
Stable medication use for at least 3 months
Voluntary participation in the study
Disqualifiers
Having uncontrolled cardiopulmonary disease
Being pregnant
Having undergone recent surgery
Presence of malignancy
Trial population
Individuals aged 18-65 years who are clinically stable and diagnosed with ankylosing spondylitis according to ASAS diagnostic criteria and who are being followed up at the Rheumatology Polyclinic of the Department of Physical Medicine and Rehabilitation at Kirsehir Ahi Evran University will be included in the study.
Trial design
Case-only
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Knowledge of cardiovascular disease risk factors
This will be evaluated using The Cardiovascular Disease Risk Factors Knowledge Level scale. The maximum score that can be obtained from the 28-question scale is 28.Higher scores on the scale indicate better knowledge of cardiovascular disease.
Healthy lifestyle behaviors
It will be evaluated with the Healthy Lifestyle Behaviors scale II.The lowest score on the whole scale is 52 and the highest is 208. As the score obtained from the survey increases, it is assumed that the participant's level of healthy lifestyle behaviour is high.
Secondary outcomes
Physical activity
Physical activity level will be evaluated using International Physical Activity Questionnaire-Short form
Cardiovascular risk
The Framingham Risk Score will be calculated to determine cardiovascular risk. Framingham risk score; if the estimated risk of cardiovascular events is above 10%, the risk is considered high; if it is below 10%, the risk is considered low.
Comorbidity
Comorbidity level will be evaluated with the Charlson Comorbidity Index
Sponsors and contacts
Click on the lead sponsor to view all of their trials.